With supplier issue now resolved, the Minnesota-run medtech company expects to “reach and then exceed” market growth in the ...

Treatment with the Type 2 diabetes medication metformin, lifestyle changes, or a combination of both did not improve atrial ...

Abbott’s Amulet IDE trial put its left atrial appendage closure device up against the Watchman 2.5, which was approved by the ...

Abbott (NYSE:ABT) announced new data supporting its Amplatzer Amulet left atrial appendage (LAA) occluder system.

Abbott has reported late-breaking five-year positive data from a trial of its Amplatzer Amulet left atrial appendage (LAA) ...

(JAMA Network Open) Among patients undergoing isolated coronary artery bypass grafting, partial cardiac denervation helped ...

Atrial fibrillation, or Afib, is the most common type of heart arrhythmia. Afib increases your risk of heart attack and ...

Boston Scientific, Medtronic and J&J are moving quickly to secure their place in the fast-growing pulsed field ablation space ...

Prescribing anti-clotting medications to adults younger than age 65 who have atrial fibrillation (AFib) but no other risk ...

Left atrial appendage closure is an alternative strategy for stroke prophylaxis, Wazni and colleagues noted. "The safety and ...

The company uses a novel machine learning algorithm, IntelliSense AFib, to analyze pressure pulse waves generated during ...

A clinical trial with adults who have atrial fibrillation (AFib) and an implanted heart device found similar improvements to the amount of time they experienced arrhythmia regardless of whether they ...